Waiv is an Owkin spinout. The funding announcement states the round was led by Alpha Intelligence Capital, with Serena Data Ventures and SistaFund participating. Some investor names appear to be missing in the source text. The company mentions partnerships such as MSD and benefits from the PortrAIt consortium.
About Waiv
Waiv (Formerly Owkin Dx) is an AI diagnostics startup that turns digital pathology and clinical data into precision oncology tests for biomarker discovery and outcome prediction, using routine slides and its Destra platform.
Paris, France
Read Company ProfileFrequently Asked Questions
What type of funding round did Waiv raise?
Waiv raised a unspecified round.
How much did Waiv raise in its unspecified?
Waiv raised $33,000,000 USD in its unspecified.
When did Waiv raise its unspecified?
Waiv raised its unspecified on 2026-03-12.
Who invested in Waiv's unspecified?
The investors in Waiv's unspecified are: Alpha Intelligence Capital, Serena Data Ventures, SistaFund.
What type of investment was Waiv's unspecified?
Waiv's unspecified was a equity investment.
How will Waiv use the funds from its unspecified?
Waiv plans to use the funds for: grow test offerings, deepen pharma R&D partnerships, expand globally, support biomarker discovery and clinical trials, broaden access to labs worldwide.